Organs-on-Chips Market Size Worth USD 209.4 Million in 2028

Growing demand for organs-on-chips for drug development and screening to reduce monetary losses associated with drug failures is a significant factor driving global organs-on-chips market growth


The global organs-on-chips market size is expected to reach USD 209.4 Million at a steady CAGR of 28.1% in 2028, according to latest analysis by Emergen Research. Steady market revenue growth can be attributed to growing demand for organs-on-chips for drug development and screening to reduce monetary losses associated with drug failures. The cost-effectiveness, miniaturized scale, and accurate control of organs-on-chips over the mechanical and chemical microenvironment are garnering significant traction across pharmaceutical and biotechnology companies to reduce rate of drug failure. Currently, two-dimensional novel drugs screening and in-vitro pharmacokinetics and pharmacodynamics analysis are prevalent practices before a drug can be sent to the next phase, such as preclinical testing phase. However, human body organs are three-dimensional entities and their intricate behavior cannot be effectively modeled in two-dimensional cultures. Use of organs-on-chips provide a microenvironment that mimics the pathophysiological conditions of the human body and thus, helps in saving substantial financial losses by substituting the trial and error method with a more reliable and efficient process.

Cardiovascular disease is a leading cause of deaths worldwide. The advent of organs-on-chips has allowed conducting of invitro cardiac tissue’s bionic researches. A heart-on-chip reproduces heart mechanisms to test drug compounds quickly and study the heart cells’ response. The microphysiological heart-on-chip provides a simple and cost-effective means to study cardiovascular diseases, develop drugs and test cardiotoxicity, provide personalized medication, and regenerate damaged tissues.

Organs-on-chips, including liver, lungs, brain, or heart deliver an enhanced functionality level and biology control to imitate the effects that would occur by the application of a personal care and cosmetic product in the human biological system and, thus, helps to predict effectiveness of a cosmetic product and its side-effects on humans.

Organs-on-chips market in North America accounted for largest revenue share in 2020, attributed to increasing research and development activities of organs-on-chips, rapid adoption of advanced technologies, and increased investments by pharmaceutical companies in drug discovery. In addition, presence of leading firms providing organs-on-chips are causative of robust market growth in the region.

To get leading market solutions, visit the link below: